Thomas A. Spizzo
Tom Spizzo is the Executive Director of Spring Point Project, where he has served the organization from its founding in 2005. He is passionate about and committed to accomplishing Spring Point Project’s mission to be the preeminent source of viable medical grade porcine tissue utilized to cure diseases, with the primary commitment to diabetes.
Tom has extensive experience leading technical projects, from construction to international dossier submission. In his role as Executive Director he leads the organization and leads day-to-day operations including Source Animal Facility (SAF) design, construction, operation, and renovation; human resources, policy, procedures, production, quality, compliance, planning, public relations, legal, IT, finance, and fundraising.
Prior to joining Spring Point Project, he was an analytical technical services officer for the Personal Healthcare division of the Procter and Gamble Company, serving as a central contact for international production, validation and laboratory issues for all OTC personal health care products. He was involved in the dossier submission to market Peptol Bismol in the UK and EU. He has also worked in several capacities in the FDA-regulated pharmaceutical industry including process, cleaning, and analytical method validation; quality control, quality assurance, and analytical method development.
Tom holds Bachelor of Science degrees in both biology and chemistry with cell biology, molecular genetics, and biochemistry emphases. He has a research background and has been published in several peer-reviewed journals, including the journal Xenotransplantation where he was the lead author of the First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2a: source pigs--preventing xenozoonoses, and Pathogen elimination and prevention within a regulated, Designated Pathogen Free, closed pig herd for long-term breeding and production of xenotransplantation materials.
Tom is a full member of the International Pancreas and Islet Transplantation Association (IPITA), and an associate member of the International Xenotransplantation Association (IXA) and Sigma Xi, The Scientific Research Society.
13:40 - 15:10
|Session — Towards Safe Donor Pigs||Maintaining donor pigs under DPF conditions - state of the art||Audimax Auditorium (A.030)|